Heart Failure pp 171-193 | Cite as

Acute Decompensated Heart Failure: Presentation, Physical Exam, and Laboratory Evaluation

  • Daniel Fishbein


ADHF may be a manifestation of any abnormality of cardiovascular function. Most patients have a prior history of heart failure. Patients with chronic heart failure may have a history of gradually worsening symptoms of pulmonary and systemic venous congestion over several days to weeks or may have more rapid development of symptoms commonly associated with a clear precipitant (examples: new onset atrial fibrillation with rapid ventricular response in a patient with HFpEF; ACS in a patient with an ischemic cardiomyopathy). Approximately 25 % of patients with ADHF have new onset or de novo heart failure – many of these patients have associated ACS or poorly controlled hypertension [1].


Heart Failure Chronic Heart Failure Acute Heart Failure Right Atrial Right Atrial Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al; ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149(2):209–16.Google Scholar
  2. 2.
    Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24(5):442–63.Google Scholar
  3. 3.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, et al; OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50(8):768–777. PubMed PMID 17707182.Google Scholar
  4. 4.
    Fonarow GC, Corday E, ADHERE Scientific Advisory Committee. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev. 2004;9(3):179–85.CrossRefPubMedGoogle Scholar
  5. 5.
    Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW, ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, et al; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296(18):2217–2226.Google Scholar
  7. 7.
    Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al; EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006 27(22):2725–36. Epub 2006 Sep 25.Google Scholar
  8. 8.
    Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261(6):884–8 PubMed PMID 2913385.CrossRefPubMedGoogle Scholar
  9. 9.
    Drazner MH, Hellkamp AS, Leier CV, Shah MR, Miller LW, Russell SD, et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail. 2008;1(3):170–7. doi: 10.1161/CIRCHEARTFAILURE.108.769778.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ely JW, Osheroff JA, Chambliss ML, Ebell MH. Approach to leg edema of unclear etiology. J Am Board Fam Med. 2006;19(2):148–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. Section 12: Evaluation and Management of Patients with Acute Decompensated Heart Failure. J Card Fail. 2010;16(6):e131–56. doi: 10.1016/j.cardfail.2010.04.004.CrossRefGoogle Scholar
  12. 12.
    Leier CV, Silver MA, Massie BM, Young JB, Fowler MB, Ventura HO, Hershberger RE. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1 – the medical history. Congest Heart Fail. 2001;7(5):245–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Payvar S, Spertus JA, Miller AB, Casscells SW, Pang PS, Zannad F, et al; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Investigators. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial. Eur J Heart Fail 2013;15(12):1382–1389. doi:  10.1093/eurjhf/hft113. Epub 2013 Jul 15.
  14. 14.
    Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, et al. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013;18(2):107–22. doi: 10.1007/s10741-012-9315-1.CrossRefPubMedGoogle Scholar
  15. 15.
    Leier CV, Young JB, Levine TB, Pina I, Armsrtrong W, Fowler MB, et al. Nuggest, pearls, and vignettes of master heart failure clinicians. Part 2—the physical examination. Congest Heart Fail. 2001;7(6):297–308 PubMed PMID 11828174.CrossRefPubMedGoogle Scholar
  16. 16.
    Weintraub NL, Collins SP, Pang PS, Levy PD, Anderson AS, Arslanian-Engoren C, et al; American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010;122(19):1975–96. doi:10.1161/CIR.0b013e3181f9a223. Epub 2010 Oct 11.Google Scholar
  17. 17.
    Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10(2):165–9. doi: 10.1016/j.ejheart.2008.01.007.CrossRefPubMedGoogle Scholar
  18. 18.
    Cotter G, Felker GM, Adams KF, Milo-Cotter O, O'Connor CM. The pathophysiology of acute heart failure--is it all about fluid accumulation? Am Heart J. 2008;155(1):9–18.CrossRefPubMedGoogle Scholar
  19. 19.
    Collins S, Storrow AB, Albert NM, Butler J, Ezekowitz J, Felker GM, et al; SAEM/HFSA Acute Heart Failure Working Group. Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working group. J Card Fail 2015;21(1):27–43. doi:  10.1016/j.cardfail.2014.07.003. Epub 2014 Jul 18.
  20. 20.
    Peacock WF, Chandra A, Char D, Collins S, Der Sahakian G, Ding L, et al. Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO). Am Heart J. 2014;167(4):529–36. doi: 10.1016/j.ahj.2013.12.023 .Epub 2014 Jan 15CrossRefPubMedGoogle Scholar
  21. 21.
    Cotter G, Metzkor E, Kaluski E, Faigenberg Z, Miller R, Simovitz A, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet. 1998;351(9100):389–93.CrossRefPubMedGoogle Scholar
  22. 22.
    Levy P, Compton S, Welch R, Delgado G, Jennett A, Penugonda N, et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007;50(2):144–52 . Epub 2007 May 23.CrossRefPubMedGoogle Scholar
  23. 23.
    Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. 2003;41(10):1797–804 PubMed PMID 12767667.CrossRefPubMedGoogle Scholar
  24. 24.
    Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest. 2004;125(2):669–82.CrossRefPubMedGoogle Scholar
  25. 25.
    Leier CV, Chatterjee K. The physical examination in heart failure--Part I. Congest Heart Fail. 2007;13(1):41–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Chaudhry A, Singer AJ, Chohan J, Russo V, Lee C. Interrater reliability of hemodynamic profiling of patients with heart failure in the ED. Am J Emerg Med. 2008;26(2):196–201. doi: 10.1016/j.ajem.2007.04.029.CrossRefPubMedGoogle Scholar
  27. 27.
    Stein JH, Neumann A, Marcus RH. Comparison of estimates of right atrial pressure by physical examination and echocardiography in patients with congestive heart failure and reasons for discrepancies. Am J Cardiol. 1997;80(12):1615–8.CrossRefPubMedGoogle Scholar
  28. 28.
    McGee SR. Physical examination of venous pressure: a critical review. Am Heart J. 1998;136(1):10–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Cook DJ, Simel DL. The Rational Clinical Examination. Does this patient have abnormal central venous pressure? JAMA. 1996;275(8):630–4.CrossRefPubMedGoogle Scholar
  30. 30.
    Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Stevenson LW, et al. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant. 1999;18(11):1126–32 PubMed PMID 10598737.CrossRefPubMedGoogle Scholar
  31. 31.
    Drazner MH, Brown RN, Kaiser PA, Cabuay B, Lewis NP, Semigran MJ, et al. Relationship of right-and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysis. J Heart Lung Transplant. 2012;31(1):67–72 PubMed PMID 22071240.CrossRefPubMedGoogle Scholar
  32. 32.
    Campbell P, Drazner MH, Kato M, Lakdawala N, Palardy M, Nohria A, et al. Mismatch of right- and left-sided filling pressures in chronic heart failure. J Card Fail. 2011;17(7):561–8 PubMed PMID 21703528.CrossRefPubMedGoogle Scholar
  33. 33.
    Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345(8):574–81 . PubMed PMID 11529211.CrossRefPubMedGoogle Scholar
  34. 34.
    Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, et al. Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA. 2005;293(18):2238–44.CrossRefPubMedGoogle Scholar
  35. 35.
    Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944–56.CrossRefPubMedGoogle Scholar
  36. 36.
    Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW, et al. Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation. 2000;102(19):2443–56 PubMed PMID 11067802.CrossRefPubMedGoogle Scholar
  37. 37.
    Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29(19):2388–442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17.Google Scholar
  38. 38.
    Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D, et al. Everest Investigators.Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail. 2013;19(6):390–7. doi: 10.1016/j.cardfail.2013.04.001 .Epub 2013 May 14.PMID:23743487 [PubMed – indexed for MEDLINE]CrossRefPubMedGoogle Scholar
  39. 39.
    Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M; Italian survey on Acute Heart Failure Investigators. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27(10):1207–15. Epub 2006 Apr 7. PMID:16603579 [PubMed – indexed for MEDLINE 1.Google Scholar
  40. 40.
    Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351(6):543–51.CrossRefPubMedGoogle Scholar
  41. 41.
    Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;154(2):277.e1–8.CrossRefGoogle Scholar
  42. 42.
    Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–39. doi: 10.1016/j.jacc.2008.07.051.CrossRefPubMedGoogle Scholar
  43. 43.
    McCullough PA, Kellum JA, Haase M, Müller C, Damman K, PT M, et al. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:82–98. doi: 10.1159/000349966 .Epub 2013 May 13CrossRefPubMedGoogle Scholar
  44. 44.
    Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol. 2008;52(7):501–11. doi: 10.1016/j.jacc.2008.04.044.CrossRefPubMedGoogle Scholar
  45. 45.
    Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818–27. doi: 10.1016/j.jacc.2008.04.061.CrossRefPubMedGoogle Scholar
  46. 46.
    Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, et al; OPTIMIZE-HF Investigators and Coordinators. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008;101(2):223-230. doi:  10.1016/j.amjcard.2007.07.067.
  47. 47.
    Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107(2):223–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Mentz RJ, Greene SJ, Ambrosy AP, Vaduganathan M, Subacius HP, Swedberg K, et al. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014;7(3):401–8. doi: 10.1161/CIRCHEARTFAILURE.113.000840 .Epub 2014 Apr 15CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Abramov D, Cohen RS, Katz SD, Mancini D, Maurer MS. Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions. Am J Cardiol. 2008;102(8):1069–72. doi: 10.1016/j.amjcard.2008.05.058 .Epub 2008 Jul 31CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107(2):226–9 PMID:12538419 [PubMed – indexed for MEDLINE].CrossRefPubMedGoogle Scholar
  51. 51.
    Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol. 2011;58(12):1241–51. doi: 10.1016/j.jacc.2011.04.040.CrossRefPubMedGoogle Scholar
  52. 52.
    de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, et al. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol. 2006;98(3):391–8 Epub 2006 Jun 12.CrossRefPubMedGoogle Scholar
  53. 53.
    Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol. 2006;48(12):2485–9 Epub 2006 Nov 28. PMID: 17174186.CrossRefPubMedGoogle Scholar
  54. 54.
    Huehnergarth KV, Mozaffarian D, Sullivan MD, Crane BA, Wilkinson CW, Lawler RL, et al. Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am J Cardiol. 2005;95(12):1492–5.CrossRefPubMedGoogle Scholar
  55. 55.
    Vaduganathan M, Ambrosy AP, Greene SJ, Mentz RJ, Subacius HP, et al; EVEREST trial investigators. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail 2012;5(6):750–758. doi:  10.1161/CIRCHEARTFAILURE.112.970525. Epub 2012 Oct 9.
  56. 56.
    Milo-Cotter O, Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, et al. Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study. Cardiology. 2010;117(3):190–6. doi: 10.1159/000321416 .Epub 2010 Nov 17CrossRefPubMedGoogle Scholar
  57. 57.
    van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail. 2010;16(1):84–90. doi: 10.1016/j.cardfail.2009.08.002 .Epub 2009 Sep 26CrossRefPubMedGoogle Scholar
  58. 58.
    Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, et al; EVEREST trial investigators. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 2012;14(3):302–311.Google Scholar
  59. 59.
    Weisberg IS, Jacobson IM. Cardiovascular diseases and the liver. Clin Liver Dis. 2011;15(1):1–20. doi: 10.1016/j.cld.2010.09.010 .Review. PMID: 21111990CrossRefPubMedGoogle Scholar
  60. 60.
    Kavoliuniene A, Vaitiekiene A, Cesnaite G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view. Int J Cardiol. 2013;166(3):554–8. doi: 10.1016/j.ijcard.2012.05.003 .Epub 2012 May 30. Review. PMID: 22656043CrossRefPubMedGoogle Scholar
  61. 61.
    Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357–68.CrossRefPubMedGoogle Scholar
  62. 62.
    Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett Jr JC, GS F, et al. BNP Consensus Panel BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004;10(5 Suppl 3):1–30.CrossRefGoogle Scholar
  63. 63.
    Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347(3):161–167.Google Scholar
  64. 64.
    Januzzi Jr JL, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948–54.CrossRefPubMedGoogle Scholar
  65. 65.
    Januzzi Jr JL, Chen-Tournoux AA, Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol. 2008;101(3A):29–38. doi: 10.1016/j.amjcard.2007.11.017.CrossRefPubMedGoogle Scholar
  66. 66.
    Maisel A, Mueller C, Adams Jr K, Anker SD, Aspromonte N, Cleland JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824–39. doi: 10.1016/j.ejheart.2008.07.014 .Epub 2008 Aug 29CrossRefPubMedGoogle Scholar
  67. 67.
    Gopal DJ, Iqbal MN, Maisel A. Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med. 2011;123(6):102–13. doi: 10.3810/pgm.2011.11.2500.CrossRefPubMedGoogle Scholar
  68. 68.
    O'Hanlon R, O'Shea P, Ledwidge M, O'Loughlin C, Lange S, Conlon C, et al. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail. 2007;13(1):50–5.CrossRefPubMedGoogle Scholar
  69. 69.
    Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006;152(5):828–34.CrossRefPubMedGoogle Scholar
  70. 70.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH,et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;128(16):e240–e327. doi:  10.1161/CIR.0b013e31829e8776. Epub 2013 Jun 5.
  71. 71.
    Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, et al. Universal definition of myocardial infarction. Circulation 2007;116(22):2634–2653. Epub 2007 Oct 19.Google Scholar
  72. 72.
    Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56(14):1071–8. doi: 10.1016/j.jacc.2010.06.016.CrossRefPubMedGoogle Scholar
  73. 73.
    O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–425. doi: 10.1161/CIR.0b013e3182742cf6. Epub 2012 Dec 17. No abstract available. Erratum in: Circulation. 2013 Dec 24;128(25):e481.Google Scholar
  74. 74.
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 127(23):e663–828. doi: 10.1161/CIR.0b013e31828478ac. Epub 2013 Apr 29. No abstract available. Erratum in: Circulation. 2013 Jun 18;127(24):e863–4.Google Scholar
  75. 75.
    Knudsen CW, Omland T, Clopton P, Westheim A, Abraham WT, Storrow AB, et al. Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med. 2004;116(6):363–8.CrossRefPubMedGoogle Scholar
  76. 76.
    Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F, et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail. 2000;2(2):123–32.CrossRefPubMedGoogle Scholar
  77. 77.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287(12):1531–40.Google Scholar
  78. 78.
    Cuffe MS, Califf RM, Adams Jr KF, Benza R, Bourge R, Colucci WS, et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541–7.CrossRefPubMedGoogle Scholar
  79. 79.
    McManus DD, Saczynski JS, Lessard D, Kinno M, Pidikiti R, Esa N, et al. Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study). Am J Cardiol. 2013;111(10):1460–5. doi: 10.1016/j.amjcard.2013.01.298.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Mountantonakis SE, Grau-Sepulveda MV, Bhatt DL, Hernandez AF, Peterson ED, Fonarow GC. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. Circ Heart Fail. 2012;5(2):191–201. doi: 10.1161/CIRCHEARTFAILURE.111.965681 .Epub 2012 Feb 23CrossRefPubMedGoogle Scholar
  81. 81.
    Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr,et al; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 2008;299(22):2656-2666. doi:  10.1001/jama.299.22.2656.
  82. 82.
    Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J. 2011 Jul;162(1):142–53.e1. doi: 10.1016/j.ahj.2011.03.033. Epub 2011 Jun 15.Google Scholar
  83. 83.
    Huvelle E, Fay R, Alla F, Cohen Solal A, Mebazaa A, Zannad F. Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort. Eur J Heart Fail. 2010;12(2):156–63. doi: 10.1093/eurjhf/hfp180 .Epub 2009 Dec 21CrossRefPubMedGoogle Scholar
  84. 84.
    Petrie MC. It cannot be cardiac failure because the heart is not enlarged on the chest X-ray. Eur J Heart Fail. 2003;5(2):117–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Pistolesi M, Miniati M, Bonsignore M, Andreotti F, Di Ricco G, Marini C. Factors affecting regional pulmonary blood flow in chronic ischemic heart disease. J Thorac Imaging. 1988;3(3):65–72.CrossRefPubMedGoogle Scholar
  86. 86.
    Ketai LH, Godwin JD. A new view of pulmonary edema and acute respiratory distress syndrome. J Thorac Imaging. 1998;13(3):147–71.CrossRefPubMedGoogle Scholar
  87. 87.
    Connolly MA. Black, white, and shades of gray: common abnormalities in chest radiographs. AACN Clin Issues. 2001;12(2):259–69 ; quiz 330-2.CrossRefPubMedGoogle Scholar
  88. 88.
    Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler KM, Myerberg RJ. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90(3):353–9.CrossRefPubMedGoogle Scholar
  89. 89.
    Collins SP, Lindsell CJ, Storrow AB, Abraham WT; ADHERE Scientific Advisory Committee, Investigators and Study Group. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 2006;47(1):13–8. Epub 2005 Jun 20.Google Scholar

Copyright information

© Springer-Verlag London 2017

Authors and Affiliations

  1. 1.Department of Medicine, Division of CardiologyUniversity of Washington Medical CenterSeattleUSA

Personalised recommendations